TXTM (ProText Mobility) Total Liabilities: $6.58 Mil (As of Sep. 2014)


What is ProText Mobility Total Liabilities?

ProText Mobility TXTM -3.00% Total Liabilities is $6.58 Mil as of Sep. 2014.

ProText Mobility's Total Liabilities for the quarter that ended in Sep. 2014 was $6.58 Mil.

ProText Mobility's quarterly Total Liabilities increased from Mar. 2014 ($6.02 Mil) to Jun. 2014 ($6.54 Mil) and increased from Jun. 2014 ($6.54 Mil) to Sep. 2014 ($6.58 Mil).

ProText Mobility's annual Total Liabilities increased from Dec. 2011 ($2.90 Mil) to Dec. 2012 ($4.46 Mil) and increased from Dec. 2012 ($4.46 Mil) to Dec. 2013 ($5.70 Mil).

ProText Mobility Total Liabilities Historical Data

* Premium members only.

The historical data trend for ProText Mobility's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

ProText Mobility Total Liabilities Chart

ProText Mobility Annual Data
Trend Dec04 Dec05 Dec06 Dec07 Dec08 Dec09 Dec10 Dec11 Dec12 Dec13
Total Liabilities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 3.32 2.08 2.90 4.46 5.70

ProText Mobility Quarterly Data
Dec09 Mar10 Jun10 Sep10 Dec10 Mar11 Jun11 Sep11 Dec11 Mar12 Jun12 Sep12 Dec12 Mar13 Jun13 Sep13 Dec13 Mar14 Jun14 Sep14
Total Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 5.44 5.70 6.02 6.54 6.58

ProText Mobility Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

ProText Mobility's Total Liabilities for the fiscal year that ended in Dec. 2013 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=4.194+(0.004+1.505
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit+NonCurrent Deferred Income Tax)
+0+0+0)
=5.70

Total Liabilities=Total Assets (A: Dec. 2013 )-Total Equity (A: Dec. 2013 )
=0.005--5.699
=5.70

ProText Mobility's Total Liabilities for the quarter that ended in Sep. 2014 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=4.722+(0+0.00099999999999922
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit+NonCurrent Deferred Income Tax)
+0+0+0)
=6.58

Total Liabilities=Total Assets (Q: Sep. 2014 )-Total Equity (Q: Sep. 2014 )
=0.02--6.558
=6.58

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Liabilities →
What does a Total Liabilities of $6.58 Mil mean?
ProText Mobility (TXTM) has a Total Liabilities of $6.58 Mil as of Sep. 2014. The total amount of liabilities as recorded on a company's balance sheet. View historical data for ProText Mobility and its competitors.
Is ProText Mobility's Total Liabilities too high?
ProText Mobility's current Total Liabilities is $6.58 Mil.
How does ProText Mobility's Total Liabilities compare to DRSV and YPPN?
ProText Mobility's Total Liabilities of $6.58 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Liabilities for a Biotechnology company?
A good Total Liabilities depends on the Biotechnology industry context. However, Total Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Liabilities mean?
A high Total Liabilities can signal that a stock is expensive relative to its fundamentals. The total amount of liabilities as recorded on a company's balance sheet. View historical data for ProText Mobility and its competitors. ProText Mobility's current Total Liabilities is $6.58 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is ProText Mobility stock overvalued right now?
ProText Mobility (TXTM) has a current Total Liabilities of $6.58 Mil. The current Total Liabilities is $6.58 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Liabilities calculated?
Total Liabilities is calculated from a company's financial statements. For ProText Mobility (TXTM), the current Total Liabilities is $6.58 Mil as of Sep. 2014. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

ProText Mobility Business Description

Address One West Las Olas Boulevard, Suite 500, Fort Lauderdale, FL, USA, 33301
ProText Mobility Inc is a Biotech Company developing a Hemp/CBD-Cannabis medicines platform for the legal cannabis industry, using proprietary live plant extraction processes and technologies. Protext has engaged in the research, testing, and development of bioavailable botanical products, all-natural ingredients formulated for nutraceuticals and pharmaceutical applications through proprietary live plant extraction technology.